Price (delayed)
$2.7
Market cap
$16.02M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$4.38
Enterprise value
$16.64M
AIkido Pharma Inc. was initially formed in 1967 and is a biotechnology company with a diverse portfolio of small-molecule anti-cancer therapeutics. The Company's platform consists of patented technology from leading
There are no recent dividends present for DOMH.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.